The BioRef neutron instrument to be set up again at ANSTO in Australia

BioRef was transported from HZB on December 19, 2016 and shipped to Australia. The trip will take about two months.

BioRef was transported from HZB on December 19, 2016 and shipped to Australia. The trip will take about two months. © D. Höcker/HZB

The BioRef neutron instrument commenced its roughly two-month journey from HZB to Australia on December 19, 2016. It will be set up again at the OPAL neutron source there, part of the Australian Nuclear Science and Technology Organisation (ANSTO) in Sydney. It is expected to be available to the international scientific community beginning in 2018 under the name "Spatz".

ANSTO operates the OPAL neutron source as part of the Centre for Neutron Scattering in the Lucas Heights quarter of Sydney. OPAL is one of the newest and most successful neutron sources in the world and ANSTO is planning further expansion of the neutron source and neutron research.

There has been close cooperation with the HZB for several years, in particular in research on energy materials. The two institutions entered into a new agreement in October 2016 to intensify this cooperation. Among other aspects, they will strive for an active exchange of ANSTO and HZB scientists, and they intend to cooperate more closely in the area of support for junior scientists as well. ANSTO is taking over the BioRef reflectometer, which facilitates research on soft matter, solid/liquid interfaces, and thin films, from the BER II neutron source in Berlin that will close at the end of 2019.

BioRef was packed up in December and shipped to Australia. It will be set up anew at ANSTO and commissioned in 2017. It will then become available for research again beginning in 2018 under the name “Spatz”, a reference to its German origins. Instrument time will be explicitly reserved there for the German user group.

In order to ensure the transfer of knowledge to the neutron community and the continued use of neutron instruments, HZB is also working on cooperative agreements with other research institutions in Europe and the world.

red.

  • Copy link

You might also be interested in

  • Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    Science Highlight
    09.09.2024
    Green hydrogen: MXenes shows talent as catalyst for oxygen evolution
    The MXene class of materials has many talents. An international team led by HZB chemist Michelle Browne has now demonstrated that MXenes, properly functionalised, are excellent catalysts for the oxygen evolution reaction in electrolytic water splitting. They are more stable and efficient than the best metal oxide catalysts currently available. The team is now extensively characterising these MXene catalysts for water splitting at the Berlin X-ray source BESSY II and Soleil Synchrotron in France.
  • SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beer
    News
    04.09.2024
    SpinMagIC: 'EPR on a chip' ensures quality of olive oil and beer
    The first sign of spoilage in many food products is the formation of free radicals, which reduces the shelf-life and the overall quality of the food. Until now, the detection of these molecules has been very costly for the food companies. Researchers at HZB and the University of Stuttgart have developed a portable, small and inexpensive 'EPR on a chip' sensor that can detect free radicals even at very low concentrations. They are now working to set up a spin-off company, supported by the EXIST research transfer programme of the German Federal Ministry of Economics and Climate Protection. The EPRoC sensor will initially be used in the production of olive oil and beer to ensure the quality of these products.
  • Review on ocular particle therapy (OPT) by international experts
    Science Highlight
    03.09.2024
    Review on ocular particle therapy (OPT) by international experts
    A team of leading experts in medical physics, physics and radiotherapy, including HZB physicist Prof. Andrea Denker and Charité medical physicist Dr Jens Heufelder, has published a review article on ocular particle therapy. The article appeared in the Red Journal, one of the most prestigious journals in the field. It outlines the special features of this form of eye therapy, explains the state of the art and current research priorities, provides recommendations for the delivery of radiotherapy and gives an outlook on future developments.